Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,169,406
+$2,340,334 QoQ
Shares Held
370,693
-10.8% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
7.66%
of 13F equity value
Holder Rank
#91
of 751 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Krensavage Asset Management, LLC holds $164,705,918 across 9 Biotechnology names. EXEL ranks #4 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ENTA |
Enanta Pharmaceuticals Inc
|
2,866,138 | $41,788,292 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
167,816 | $40,438,621 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
524,786 | $30,028,254 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
370,693 | $20,169,406 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
390,879 | $13,051,449 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
|
1,180,388 | $7,223,974 | |
| 7 | BNTX |
BioNTech SE
|
59,523 | $5,538,615 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,000 | $3,741,240 |
All Filings in EXEL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,169,406 | 370,693 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,829,072 | 415,693 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $21,631,244 | 493,526 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $21,415,123 | 518,526 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $21,754,626 | 493,526 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $32,435,438 | 878,533 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $32,163,337 | 965,866 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $33,257,831 | 1,281,612 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $37,691,020 | 1,677,393 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $37,164,502 | 1,566,140 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $45,558,905 | 1,899,079 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $41,496,449 | 1,899,151 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $40,775,064 | 2,133,703 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $41,457,197 | 2,135,868 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $34,294,145 | 2,138,039 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $28,560,728 | 1,821,475 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $31,373,345 | 1,506,885 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $34,694,304 | 1,530,406 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $28,464,135 | 1,557,119 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $21,140,000 | 1,000,000 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||